Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-10

Clinical Trial Update: Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy and rituximab with or without total-body irradiation and peripheral stem cell transplant in lymphoma; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-10